$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

$olpx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000186872623000096 Filed on November 07, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$111.7M	$123.6M
YoY Change	-14.54%	-29.98%
Cost Of Revenue	$34.94M	$40.01M
YoY Change	-9.56%	-14.2%
Gross Profit	$76.78M	$83.55M
YoY Change	-16.63%	-35.65%
Gross Profit Margin	68.73%	67.62%
Selling, General & Admin	$49.17M	$36.43M
YoY Change	41.93%	18.26%
% of Gross Profit	64.04%	43.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.63M	$13.00M
YoY Change	-2.37%	25.86%
% of Gross Profit	16.44%	15.56%
Operating Expenses	$59.62M	$46.81M
YoY Change	32.37%	13.8%
Operating Profit	$17.16M	$36.74M
YoY Change	-63.52%	-58.58%
Interest Expense	-$8.867M	$9.510M
YoY Change	-15.75%	-9.42%
% of Operating Profit	-51.66%	25.89%
Other Income/Expense, Net	$1.548M	-$970.0K
YoY Change	-3.01%	-56.91%
Pretax Income	$17.25M	$26.26M
YoY Change	-58.14%	-65.42%
Income Tax	$3.147M	$5.891M
% Of Pretax Income	18.25%	22.44%
Net Earnings	$14.10M	$20.37M
YoY Change	-58.07%	-66.48%
Net Earnings / Revenue	12.62%	16.48%
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	$0.02	$0.03
COMMON SHARES
Basic Shares Outstanding	654.7M shares	654.7M shares
Diluted Shares Outstanding		678.8M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$466.4M	$429.6M
YoY Change	44.48%	72.25%
Cash & Equivalents	$466.4M	$429.6M
Short-Term Investments
Other Short-Term Assets	$9.953M	$6.418M
YoY Change	13.48%	95.85%
Inventory	$95.92M	$112.8M
Prepaid Expenses
Receivables	$40.92M	$51.88M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$613.2M	$600.6M
YoY Change	17.42%	20.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$930.0K	$929.0K
YoY Change	-10.06%	51.3%
Goodwill	$168.3M	$168.3M
YoY Change	0.0%	0.0%
Intangibles	$947.7M	$959.9M
YoY Change	-4.76%	-4.71%
Long-Term Investments
YoY Change
Other Assets	$10.20M	$12.44M
YoY Change	-8.03%	18.51%
Total Long-Term Assets	$1.127B	$1.142B
YoY Change	-4.11%	-4.84%
TOTAL ASSETS
Total Short-Term Assets	$613.2M	$600.6M
Total Long-Term Assets	$1.127B	$1.142B
Total Assets	$1.740B	$1.742B
YoY Change	2.51%	2.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.073M	$13.35M
YoY Change	-27.44%	-42.28%
Accrued Expenses	$20.58M	$17.41M
YoY Change	20.28%	-33.12%
Deferred Revenue	$1.051M	$1.235M
YoY Change	-47.84%	-74.74%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.750M	$6.750M
YoY Change	-20.0%	0.0%
Total Short-Term Liabilities	$56.14M	$56.20M
YoY Change	1.91%	-36.55%
LONG-TERM LIABILITIES
Long-Term Debt	$649.0M	$650.4M
YoY Change	-0.81%	-0.81%
Other Long-Term Liabilities	$1.694M	$1.768M
YoY Change	-99.18%	-99.15%
Total Long-Term Liabilities	$650.7M	$652.1M
YoY Change	-0.55%	-0.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.14M	$56.20M
Total Long-Term Liabilities	$650.7M	$652.1M
Total Liabilities	$895.4M	$901.8M
YoY Change	-2.33%	-5.36%
SHAREHOLDERS EQUITY
Retained Earnings	$526.4M	$512.3M
YoY Change	13.25%	18.81%
Common Stock	$671.0K	$654.0K
YoY Change	3.39%	0.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$845.0M	$840.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.740B	$1.742B
YoY Change	2.51%	2.67%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$14.10M	$20.37M
YoY Change	-58.07%	-66.48%
Depreciation, Depletion And Amortization	$12.63M	$13.00M
YoY Change	-2.37%	25.86%
Cash From Operating Activities	$49.04M	$53.40M
YoY Change	-33.3%	-0.66%
INVESTING ACTIVITIES
Capital Expenditures	$712.0K	$900.0K
YoY Change	-26.6%	-217.34%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$712.0K	-$900.0K
YoY Change	-26.6%	17.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.51M	-1.300M
YoY Change	-1435.15%	-19.55%
NET CHANGE
Cash From Operating Activities	49.04M	53.40M
Cash From Investing Activities	-712.0K	-900.0K
Cash From Financing Activities	-11.51M	-1.300M
Net Change In Cash	36.81M	51.20M
YoY Change	-49.85%	-0.33%
FREE CASH FLOW
Cash From Operating Activities	$49.04M	$53.40M
Capital Expenditures	$712.0K	$900.0K
Free Cash Flow	$48.32M	$52.50M
YoY Change	-33.39%	-3.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001868726
	dei	City Area Code CityAreaCode	310
	dei	Local Phone Number LocalPhoneNumber	691-0776
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	OLPX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322808000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	23978000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19198000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51876000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46220000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	112762000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6418000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8771000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	600642000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	522224000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	929000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1034000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12441000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11089000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176454000	usd
CY2022Q4	us-gaap	Assets Assets	1697675000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13349000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9748000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	2503000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3415000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17409000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q3	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	16184000	usd
CY2022Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	16380000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	56195000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	55088000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	650350000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4068000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1622000	usd
CY2023Q3	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	189391000	usd
CY2022Q4	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	205675000	usd
CY2022Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	45484000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	2592000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46626000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	83548000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	129828000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36433000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30807000	usd
CY2023Q3	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10378000	usd
CY2022Q3	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	10329000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	46811000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	41136000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	36737000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	88692000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	9510000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	970000	usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2251000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-970000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26257000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5891000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	678758020	shares
CY2023Q3	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-861000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-861000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19505000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	654733052	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	429586000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	959855000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	995028000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q3	us-gaap	Assets Assets	1742167000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1768000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q3	us-gaap	Liabilities Liabilities	901772000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	916718000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	654724366	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	654724366	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	650091380	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	650091380	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	654000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	649000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	324593000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312875000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2806000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2577000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	512342000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	464856000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	840395000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1742167000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1697675000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123555000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346583000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	573553000	usd
CY2023Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	37415000	usd
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	98431000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	5091000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	104729000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146090000	usd
	us-gaap	Gross Profit GrossProfit	241854000	usd
	us-gaap	Gross Profit GrossProfit	427463000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	119770000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	79232000	usd
	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	31025000	usd
	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	30890000	usd
	us-gaap	Operating Expenses OperatingExpenses	150795000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1328000	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3852000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	20366000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023Q1	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	326000	usd
CY2023Q1	olpx	Share Based Payment Arrangement Shares Withheld For Tax Withholding Obligation Amount ShareBasedPaymentArrangementSharesWithheldForTaxWithholdingObligationAmount	390000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3299000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2018000	usd
CY2023Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-557000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	806617000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	6156000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	798000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2634000	usd
CY2023Q2	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	1647000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	817852000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	20366000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	352000	usd
CY2023Q3	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-861000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	840395000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	524298000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1632000	usd
CY2022Q1	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	348000	usd
CY2022Q1	olpx	Share Based Payment Arrangement Shares Withheld For Tax Withholding Obligation Amount ShareBasedPaymentArrangementSharesWithheldForTaxWithholdingObligationAmount	920000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1696000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	679197000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	60763000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2031000	usd
CY2022Q3	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	1931000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	743996000	usd
	us-gaap	Net Income Loss NetIncomeLoss	47486000	usd
	us-gaap	Net Income Loss NetIncomeLoss	210439000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	6298000	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	5091000	usd
	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	31025000	usd
	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	30890000	usd
	olpx	Inventory Write Down And Disposal InventoryWriteDownAndDisposal	9801000	usd
	olpx	Inventory Write Down And Disposal InventoryWriteDownAndDisposal	5958000	usd
	us-gaap	Depreciation Depreciation	344000	usd
	us-gaap	Depreciation Depreciation	233000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1359000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2955000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2377000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4532000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7338000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5454000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18803000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	64000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	572000	usd
	olpx	Payment To Pre Ipo Stockholders Pursuant To Tax Receivable Agreement PaymentToPreIPOStockholdersPursuantToTaxReceivableAgreement	16452000	usd
	olpx	Payment To Pre Ipo Stockholders Pursuant To Tax Receivable Agreement PaymentToPreIPOStockholdersPursuantToTaxReceivableAgreement	0	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	675000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11944000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18817000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-117084000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	106778000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	63011000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186388000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	429586000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249399000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	9531000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	54904000	usd
	us-gaap	Interest Paid Net InterestPaidNet	21716000	usd
	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	0	usd
	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	1632000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2128000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123555000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176454000	usd
CY2023Q3	olpx	Number Of Business Channels NumberOfBusinessChannels	3	business_channel
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123555000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176454000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, variable consideration, and other obligations such as product returns, allowance for promotions, and refunds; loss contingencies; the fair value of share-based options and stock settled stock appreciation rights (“SARs”); the fair value of and/or potential impairment of goodwill and intangible assets for the Company’s reporting unit; the fair value of the Company’s interest rate cap; useful lives of the Company’s tangible and intangible assets; estimated income tax and tax receivable payments; the net realizable value of, and demand for the Company’s inventory. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented have been reclassified within “Note 6 - Accrued Expenses and Other Current Liabilities” as of </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to conform with the current period presentation, including a prior year reclassification from Other accrued expenses and current liabilities to Accrued advertising and Accrued inventory purchases. The reclassifications had no effect on the Company’s Total current liabilities.</span></div>
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	35619000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36194000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	77143000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	108231000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	112762000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	3600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	9800000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1146585000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	186730000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	959855000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q3	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1314885000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	186730000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1128155000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1143922000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	995028000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1312222000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1163328000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4242000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3187000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3598000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4092000	usd
CY2023Q3	olpx	Accrued Freight Current AccruedFreightCurrent	2707000	usd
CY2022Q4	olpx	Accrued Freight Current AccruedFreightCurrent	3283000	usd
CY2023Q3	olpx	Accrued Inventory Purchases AccruedInventoryPurchases	2191000	usd
CY2022Q4	olpx	Accrued Inventory Purchases AccruedInventoryPurchases	1140000	usd
CY2023Q3	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	2056000	usd
CY2022Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	1356000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1235000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2015000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1129000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1220000	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	251000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	814000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17409000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7775000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8854000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	657100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	662771000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	650350000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9500000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	10500000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	30300000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	30700000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	657100000	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	555200000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	624600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	109620	shares
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	83501	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4606867	shares
	olpx	Deferred Compensation Arrangement With Individual Converted In Period Number Of Units DeferredCompensationArrangementWithIndividualConvertedInPeriodNumberOfUnits	886950	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	117180	shares
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	55244	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	256846	shares
	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	16600000	usd
CY2022Q3	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	4200000	usd
	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	4200000	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIES<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to various legal actions arising in the ordinary course of business. The Company cannot predict with reasonable assurance the outcome of these legal actions brought against the Company as they are subject to uncertainties. Accordingly, any settlement or resolution in these legal actions may occur and affect the Company’s net income in such period as the settlement or resolution.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending Legal Proceedings: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, a putative securities class action was filed against the Company and certain of its current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien v. Olaplex Holdings, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-08395. A consolidated complaint was filed on April 28, 2023, which names as additional defendants the underwriters for the Company’s IPO and various stockholders that sold shares of common stock of the Company in the IPO. The action is brought on behalf of a putative class of purchasers of the Company’s common stock in or traceable to the Company’s IPO and asserts claims under Sections 11, 12, and 15 of the Securities Act of 1933. The action seeks certification of the putative class, compensatory damages, attorneys’ fees and costs, and any other relief that the court determines is appropriate. The defendants moved to dismiss the consolidated complaint on July 19, 2023. The court held a hearing on the defendants’ motions to dismiss on October 16, 2023, and a decision has yet to issue. The underwriter defendants have notified the Company of their intent to seek indemnification from the Company pursuant to the IPO underwriting agreement regarding the claims asserted in this action. The Company intends to vigorously defend the pending lawsuit.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2023, twenty-eight plaintiffs filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Albahae, et al. v. Olaplex Holdings, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:23-cv-00982, a complaint alleging personal and economic injury and asserting claims for breach of warranty, negligence/gross negligence, products liability, unjust enrichment, and violations of California False Advertising Law and Unfair Competition Law, against the Company and Cosway Company, Inc., the Company’s primary contract manufacturer, in the United States District Court for the Central District of California. On March 2, 2023, the plaintiffs amended the complaint to include seventy-three additional plaintiffs. The plaintiffs allege that certain ingredients used in some Company products have purportedly caused irritation or posed a hazard to consumers, and that the Company engaged in misrepresentation with respect to those products. The plaintiffs seek actual and consequential damages, punitive damages, restitution in the form of disgorgement of profits, attorneys’ fees and costs, and any other relief that the court determines is appropriate. On April 17, 2023, the Company moved to dismiss and to sever the plaintiffs’ claims. On July 11, 2023, the Court granted the Company’s motion to sever and dismissed all but the first named plaintiff. The Court also dismissed the operative complaint with leave to re-file on the grounds that it now contained allegations that were not relevant to the claims of the one, remaining plaintiff. On July 24, 2023, the remaining plaintiff filed a notice, voluntarily dismissing her claims without prejudice. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any potential loss associated with these pending legal proceedings is not probable or reasonably estimable at this time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023 and December 31, 2022, the Company was not subject to any other currently pending legal matters or claims that could have a material adverse effect on its financial position, results of operations, or cash flows should such litigation be resolved unfavorably.</span></div>
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	28	plaintiff
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	73	plaintiff
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	20366000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	60763000	usd
	us-gaap	Net Income Loss NetIncomeLoss	47486000	usd
	us-gaap	Net Income Loss NetIncomeLoss	210439000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	654702392	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	649099780	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	653603665	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	648963625	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24055628	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	42157874	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	27485878	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	42622162	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	678758020	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	691257654	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	681089543	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	691585787	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4473909	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2887141	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1275337	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1170756	shares
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001868726-23-000096-index-headers.html	Edgar Link	pending
0001868726-23-000096-index.html	Edgar Link	pending
0001868726-23-000096.txt	Edgar Link	pending
0001868726-23-000096-xbrl.zip	Edgar Link	pending
ex102amendedrestated2020om.htm	Edgar Link	pending
ex311-ceocertificationq320.htm	Edgar Link	pending
ex312-cfocertificateq32023.htm	Edgar Link	pending
ex321-ceocertificateq32023.htm	Edgar Link	pending
ex322-cfocertificateq32023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
olpx-20230930.htm	Edgar Link	pending
olpx-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
olpx-20230930_cal.xml	Edgar Link	unprocessable
olpx-20230930_def.xml	Edgar Link	unprocessable
olpx-20230930_lab.xml	Edgar Link	unprocessable
olpx-20230930_pre.xml	Edgar Link	unprocessable
olpx-20230930_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

2023 Q4 Form 10-Q Financial Statement

#000186872623000096 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX OLAPLEX HOLDINGS, INC. Stock $olpx

2023 Q4 Form 10-Q Financial Statement

#000186872623000096 Filed on November 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx